p21-activated kinase 1: an emerging therapeutic target.
Vadlamudi
Ratna K
RK
Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, USA.
Kumar
Rakesh
R
D002453:Cell Cycle; D002465:Cell Movement; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D017346:Protein Serine-Threonine Kinases / Q000502:physiology*; D054462:p21-Activated Kinases
D004791:Enzyme Inhibitors; C515903:PAK1 protein, human; D017346:Protein Serine-Threonine Kinases; D054462:p21-Activated Kinases